中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2012年
8期
616-618
,共3页
邢彤%杨宝钟%宋盛晗%廖传军
邢彤%楊寶鐘%宋盛晗%廖傳軍
형동%양보종%송성함%료전군
动脉硬化,闭塞症%血管成形术,气囊%支架%通畅率
動脈硬化,閉塞癥%血管成形術,氣囊%支架%通暢率
동맥경화,폐새증%혈관성형술,기낭%지가%통창솔
Arteriosclerosis obliterans%Angioplasty,balloon%Stents%Patency rate
目的 探讨泛大西洋协作组织(TransAtlantic InterSociety Consensus,TASC)ⅡC、D型股腘动脉慢性闭塞腔内支架治疗的临床疗效.方法 回顾性分析2008年1月至2011年6月46例(51条下肢)TASCⅡC型和D型股腘动脉闭塞患者腔内治疗的临床资料.46例中男27例,女19例,年龄52～88岁,平均(70 ±8)岁.术前Rutherford症状分级:3级重度间歇性跛行29条,4级静息痛12条,5级轻微组织缺损6条,6级组织溃疡、坏疽4条.总结分析技术成功率、患肢术后临床症状、踝肱指数(ankle brachial index,ABI)变化,并发症发生率和通畅率.结果 技术成功率90.2％ (42/51),治疗成功者共植入支架93枚.术后ABI 0.71 ±0.23,较术前0.42 ±0.13提高,两者差异有统计学意义(t=-7.281,P＜0.01).42例技术成功者均获随访,平均随访(14.6±1.2)个月.术后6个月的一期通畅率、辅助通畅率和累积通畅率分别为81.0％、88.1％、90.5％,术后12个月的一期通畅率、辅助通畅率和累积通畅率分别为66.7％、71.8％、79.5％.结论 TASCⅡC、D型股腘动脉慢性闭塞腔内治疗是一种安全有效的方法.
目的 探討汎大西洋協作組織(TransAtlantic InterSociety Consensus,TASC)ⅡC、D型股腘動脈慢性閉塞腔內支架治療的臨床療效.方法 迴顧性分析2008年1月至2011年6月46例(51條下肢)TASCⅡC型和D型股腘動脈閉塞患者腔內治療的臨床資料.46例中男27例,女19例,年齡52～88歲,平均(70 ±8)歲.術前Rutherford癥狀分級:3級重度間歇性跛行29條,4級靜息痛12條,5級輕微組織缺損6條,6級組織潰瘍、壞疽4條.總結分析技術成功率、患肢術後臨床癥狀、踝肱指數(ankle brachial index,ABI)變化,併髮癥髮生率和通暢率.結果 技術成功率90.2％ (42/51),治療成功者共植入支架93枚.術後ABI 0.71 ±0.23,較術前0.42 ±0.13提高,兩者差異有統計學意義(t=-7.281,P＜0.01).42例技術成功者均穫隨訪,平均隨訪(14.6±1.2)箇月.術後6箇月的一期通暢率、輔助通暢率和纍積通暢率分彆為81.0％、88.1％、90.5％,術後12箇月的一期通暢率、輔助通暢率和纍積通暢率分彆為66.7％、71.8％、79.5％.結論 TASCⅡC、D型股腘動脈慢性閉塞腔內治療是一種安全有效的方法.
목적 탐토범대서양협작조직(TransAtlantic InterSociety Consensus,TASC)ⅡC、D형고객동맥만성폐새강내지가치료적림상료효.방법 회고성분석2008년1월지2011년6월46례(51조하지)TASCⅡC형화D형고객동맥폐새환자강내치료적림상자료.46례중남27례,녀19례,년령52～88세,평균(70 ±8)세.술전Rutherford증상분급:3급중도간헐성파행29조,4급정식통12조,5급경미조직결손6조,6급조직궤양、배저4조.총결분석기술성공솔、환지술후림상증상、과굉지수(ankle brachial index,ABI)변화,병발증발생솔화통창솔.결과 기술성공솔90.2％ (42/51),치료성공자공식입지가93매.술후ABI 0.71 ±0.23,교술전0.42 ±0.13제고,량자차이유통계학의의(t=-7.281,P＜0.01).42례기술성공자균획수방,평균수방(14.6±1.2)개월.술후6개월적일기통창솔、보조통창솔화루적통창솔분별위81.0％、88.1％、90.5％,술후12개월적일기통창솔、보조통창솔화루적통창솔분별위66.7％、71.8％、79.5％.결론 TASCⅡC、D형고객동맥만성폐새강내치료시일충안전유효적방법.
Objective To evaluate endovascular stenting for TASC TASC Ⅱ C/D femoropopliteal arterial disease. Methods Between January 2008 and June 2011,Endovascular treatments of 51 limbs TASC Ⅱ C/D femoropopliteal artery occlusions in 46 patients(27 male and 19 female) were retrospectively reviewed.Mean age was (70 ± 8 ) years ( range,52 years to 88 years).Severe intermittent claudication,rest pain,minor tissue defect and foot ulceration or gangrene were in 29 limbs,12 limbs,6 limbs and 4 limbs,respectively. Technical success rate,ankle brachial index (ABI),complication rate, and cumulative primary patency rate were evaluated. Results Technical success rate was 90.2％.93 stents were placed in 46 limbs of the 42 patients.Postoperative ABI was increased in all patients.42 patients(46 lower limbs) were followed up for a mean period of 14.6 months.Primary,assisted-primary,and cumulative patency rates at 6 months were 81.0％,88.1％ and 90.5％.Primary,assisted-primary,and cumulative patency rates at 12 months were 66.7％,71.8％ and 79.5％ respectively. Conclusions Endovascular treatment of TASC Ⅱ C/D femoropopliteal arterial lesions is microinvasive,safe and effective.
